Reporter, Medtech Insight
Graduating in 2020 with a Master’s degree in biomedical engineering from University College London, Barnaby is passionate about all things medtech. In his first role as a journalist, Barnaby will focus on R&D and commercial stories in medtech, and writing about emerging technologies such as digital health, artificial intelligence, machine learning, deep-brain implants, and nanoscale applications of medtech. Alongside this, Barnaby is looking forward to taking deeper dives into start-ups, device market analysis, and company financial data, to create informed, useful, and engaging content.
Barnaby lives in in rural Wiltshire, UK and is a keen reader, cyclist, and hobbyist jeweler.
Latest From Barnaby Pickering
By utilizing the properties of graphene, INBRAIN hopes to develop improved electrodes implanted in the brain, raising the potential of neuromodulation for treating complex neurological disorders.
The global market for arthroscopy products and sports medicine implants is expected to reach $6.3bn by 2025, a CAGR of 1.9% from $5.7bn in 2020. The growth is driven partly by rising arthroscopy procedure volumes, expanding indications for joint repair, and patient preference for minimally invasive procedures. COVID-19 and downward pressures on device prices are among the growth barriers.
The point-of-care and portable ultrasound markets are growing rapidly and the next evolution will be at-home imaging, according to a new report from Informa's Omdia Ultrasound Intelligence Service.
Analytica formed a joint venture Chinese partners to distribute its PeriCoach system to take advantage of the large Asian urinary incontinence market.
Device Week, 2 April 2021 – Venture Capital Viewpoints, And Exciting Financing Deals For Augmedics And NeuroPace
In this week’s podcast, Medtech Insight managing editor Reed Miller discusses Augmedics’ and NeuroPace’s financing deals, and UK-based reporter Barnaby Pickering offers some insights from Octopus Ventures, a venture capital fund based in London.
FDA grants emergency use authorization to OTC COVID-19 testing products as it targets allowing workplaces, schools and communities to access tools needed to screen for the virus rapidly and accurately.